Clinical Trial Update: A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial to assess safety and real-world effectiveness of adding darolutamide to standard androgen deprivation therapy in Indian patients with h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-metastatic Castration-resistant Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Non-metastatic Castration-resistant Prostate Cancer | Phase 4 | Status: RECRUITING